Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma
Open Access
- 24 January 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (4), 219-226
- https://doi.org/10.1056/nejm199101243240403
Abstract
Morphologic evaluation of bone marrow for neuroblastoma cells is a routine and important component of clinical staging. Specific immunostaining of malignant cells with monoclonal antibodies should be more sensitive, however, and may improve the detection of metastases and provide additional prognostic information.Keywords
This publication has 29 references indexed in Scilit:
- Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodiesEuropean Journal of Cancer and Clinical Oncology, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- A Method of Detecting Neuroblastoma in Human Bone Marrow by Means of Two Monoclonal Antibodies PI 153/3 and KE2Hybridoma, 1985
- Detection of bone marrow involvement by neuroblastoma: Comparison of two cytological methodsEuropean Paediatric Haematology and Oncology, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983
- RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMAThe Lancet, 1983
- Detection of Neuroblastoma Cells in Human Bone Marrow Using a Combination of Monoclonal AntibodiesHybridoma, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Incidence of malignant tumors in U.S. childrenThe Journal of Pediatrics, 1975